NCT06990698 A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06990464 A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients Status RECRUITING Phase PHASE1
NCT06976931 Study on the Safe Dosage and Therapeutic Effect of the Drug YY2201 Tablets on Patients With Advanced Cancer Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06973564 JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration Status RECRUITING Phase PHASE1/PHASE2
NCT06968572 Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion Status RECRUITING Phase PHASE1
NCT06963502 A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06963398 A Study of HS-10529 in KRAS G12D Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06959706 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06954558 A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor Status RECRUITING Phase PHASE1
NCT06943820 AK129 Combination Therapy for Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06932094 Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06929663 A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06927570 A Study of HS-20122 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06925659 A Study of QLM2011 in Subjects With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1
NCT06925581 A Trial of HRS-6768 in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06915753 Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations Status RECRUITING Phase PHASE1
NCT06907628 A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06907043 A Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors. Status RECRUITING Phase PHASE1/PHASE2
NCT06906731 A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2